These are some exercises for diabetes patients that will help get your core muscles (he muscles around your trunk and pelvis) in better shape.

A recent study found that patients with type 2 diabetes and treatment-resistant hypertension are at higher risk of cardiovascular events and mortality.

In this weeks Homerun Slides, we take a look at the value of glycemic control and explore the question of why type 2 diabetes should be aggressively

I work in obesity medicine. As many of us know, losing weight isnt the problem for most, but weight regain is.. As the saying goes for many, you cant be rich enough or thin enough. Many of our patients come in with unrealistic goals regarding their weight loss, and dont give themselves enough credit for the weight they have lost. Many, for many reasons, regain.. ...

Insulin use for more than three years associated with increased risk of disease... People with diabetes may be at a greater risk of cancer such as liver,

Cost-effectiveness of SGLT2 Inhibitors in Patients with Heart Failure with Reduced Ejection Fraction 1 week ago Articles, ... SGLT2 inhibitors are not created equal; patient-specific characteristics need to be considered for best efficacy. ... Oct 23, 2021 Articles, Cardiology, Nephrology, Paid, SGLT-2 Therapy Center, Type 2 Diabetes ... CREDENCE trial shows that canagliflozin, an SGLT2 inhibitor, lowers the risk of cardiovascular and renal events in patients ...

In this Exclusive Interview transcript, Kevin Sayer talks with Diabetes in Control Publisher Steve Freed about the Dexcom G6 CGM System and the future of CGMs changing diabetes management for type 1, type 2, and even prediabetes. Click here to view the video interview. Steve Freed: This is Steve Freed …. Read More » ...

Other genetic markers-the "missing heritability": Collectively the confirmed T1DM risk loci account for approximately 70% of disease heritability, with around 40-50% being attributed to the HLA genes. These figures are well in excess of the 10-20% of heritability of other complex diseases that can be explained by genetic factors. Experience from GWAS suggests that overall disease risk is likely to be influenced by many genes, most having a weak biologic effect. This may be due to the subtle effects of risk alleles on gene function or the modest contribution of individual gene products to the biologic pathways involved in disease pathogenesis. None of the confirmed T1DM risk variants have complete penetrance and are therefore neither necessary nor sufficient for disease to develop. This makes it difficult to use genetic profiling to predict disease risk as T1DM can develop in the absence of susceptibility variants and does not always occur in subjects with known risk markers. Read More » ...